Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G(2)/M cell cycle arrest

The efficacy of cisplatin-based chemotherapy in cancer is limited by the occurrence of innate and acquired drug resistance. In order to better understand the mechanisms underlying acquired cisplatin resistance, we have compared the adenocarcinoma-derived non-small cell lung cancer (NSCLC) cell line...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Sarin, Navin, Engel, Florian, Kalayda, Ganna V., Mannewitz, Mareike, Cinatl, Jindrich, Rothweiler, Florian, Michaelis, Martin, Saafan, Hisham, Ritter, Christoph A., Jaehde, Ulrich, Frötschl, Roland
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528889/
https://ncbi.nlm.nih.gov/pubmed/28746345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0181081
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados